SCHEMBL3560769

SCHEMBL3560769

CCS(=O)(=O)Nc1ccc(OCCOc2ccccc2CCC(=O)O)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.52
PPARD Q03181 2/20 0.48
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
LTB4R Q15722 2/20 0.46
LTB4R2 Q9NPC1 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
POLB P06746 1/20 0.46
DHFR P00374 1/20 0.44
SQSTM1 Q13501 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
FFAR1 O14842 3/20 0.43
PPARA Q07869 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PPARG P37231 1/20 0.43
MAPT P10636 1/20 0.42
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556582 0.91 AR (0.56) ARPPARDLMNALTB4RLTB4R2
SCHEMBL3555186 0.90 NPC1 (0.51) ARPPARDHPGDLTB4RLTB4R2
SCHEMBL3560208 0.88 AR (0.54) ARPPARDLMNAHPGDSQSTM1
SCHEMBL3554982 0.86 TDP1 (0.59) ARLMNATDP1POLBSQSTM1
SCHEMBL3551606 0.86 SMN1; SMN2 (0.58) PPARDLMNALTB4RLTB4R2TDP1
SCHEMBL3564064 0.85 TDP1 (0.47) PPARDLTB4RLTB4R2TDP1POLB
SCHEMBL3554604 0.84 TDP1 (0.60) ARLMNATDP1POLBSQSTM1
SCHEMBL3558946 0.84 KEAP1 (0.58) LMNATDP1POLBSQSTM1KEAP1
SCHEMBL3557130 0.84 ALDH1A1 (0.58) ARLMNATDP1POLBSQSTM1
SCHEMBL3556702 0.84 TDP1 (0.62) ARPPARDLMNATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 AR 3412/4885PPARD 259/4885LMNA 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.